gastric or gastroesophageal junction adenocarcinoma
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
|
| gptkbp:affects |
digestive system
|
| gptkbp:diagnosedBy |
gptkb:CT_scan
endoscopy biopsy |
| gptkbp:hasMolecularSubtype |
Epstein-Barr virus-associated
HER2-positive microsatellite instability-high |
| https://www.w3.org/2000/01/rdf-schema#label |
gastric or gastroesophageal junction adenocarcinoma
|
| gptkbp:ICD-10_code |
gptkb:C16
C15.5 |
| gptkbp:location |
gptkb:gastroesophageal_junction
stomach |
| gptkbp:prognosis |
poor
|
| gptkbp:riskFactor |
gptkb:Helicobacter_pylori_infection
gptkb:gastroesophageal_reflux_disease obesity smoking |
| gptkbp:subspecies |
gastrointestinal cancer
|
| gptkbp:symptom |
nausea
abdominal pain weight loss dysphagia |
| gptkbp:treatment |
surgery
radiation therapy chemotherapy oncologist immunotherapy |
| gptkbp:bfsParent |
gptkb:Trastuzumab_deruxtecan
|
| gptkbp:bfsLayer |
7
|